sore
throat
common
primari
healthcar
aetiolog
studi
focus
presenc
limit
number
pathogen
aim
present
studi
investig
presenc
wide
rang
bacteria
virus
includ
fusobacterium
necrophorum
patient
pharyngotonsil
asymptomat
control
prospect
case
control
studi
perform
primari
healthcar
kronoberg
counti
sweden
patient
n
age
year
suspect
acut
pharyngotonsil
control
n
includ
nasopharyng
throat
swab
analys
streptococci
f
necrophorum
mycoplasma
pneumonia
chlamydophila
pneumonia
respiratori
virus
serum
sampl
analys
antibodi
epsteinbarr
viru
patient
histori
symptom
includ
centor
score
analys
relat
pathogen
patient
compar
control
p
least
one
microorgan
found
group
streptococci
f
necrophorum
influenza
b
viru
three
common
find
significantli
common
patient
control
p
p
p
respect
patient
f
necrophorum
n
display
lower
centor
score
patient
group
streptococcu
n
higher
score
patient
influenza
b
virus
potenti
pathogen
kruskalw
p
pathogen
detect
patient
display
wide
rang
pathogen
contribut
aetiolog
pharyngotonsil
studi
support
f
necrophorum
one
pathogen
consid
aetiolog
pharyngotonsil
clinic
microbiolog
infect
sore
throat
common
complaint
primari
healthcar
phc
condit
caus
wide
varieti
infecti
agent
common
streptococcu
pyogen
group
streptococci
ga
also
larg
coloni
variant
streptococcu
group
c
g
mycoplasma
pneumonia
arcanobacterium
haemolyticum
sever
virus
associ
sore
throat
aetiolog
mainli
studi
children
studi
perform
focu
presenc
limit
number
pathogen
studi
cover
viral
bacteri
aetiolog
lack
criteria
present
centor
et
al
year
ago
develop
predict
presenc
ga
caus
patient
symptom
thu
predict
patient
consid
need
antibiot
therapi
recent
year
anaerob
gramneg
bacterium
fusobacterium
necrophorum
suggest
import
caus
acut
pharyngotonsil
adolesc
young
adult
time
author
notic
increas
sever
infect
caus
f
necrophorum
syndrom
conclus
howev
gener
accept
increas
may
due
public
bia
studi
focus
f
necrophorum
throat
pathogen
far
base
routin
clinic
microbiolog
data
focus
presenc
bacterium
aim
present
studi
investig
presenc
f
necrophorum
togeth
streptococci
mycoplasma
pneumonia
chlamydophila
pneumonia
respiratori
virus
adult
attend
phc
symptom
pharyngotonsil
compar
asymptomat
control
second
aim
investig
associ
pathogen
patient
histori
symptom
sign
relat
centor
score
particular
set
prospect
case
control
studi
conduct
five
primari
healthcar
centr
phcc
kronoberg
counti
sweden
data
collect
januari
april
octob
april
patient
patient
age
year
suspect
acut
pharyngotonsil
contact
phcc
consid
need
consult
physician
accord
nation
swedish
guidelin
recruit
accord
standard
procedur
patient
contact
phcc
via
telephon
nurs
primarili
assess
patient
symptom
call
visit
physician
inform
consent
obtain
physician
made
studi
assess
consult
includ
centor
criteria
ie
absenc
cough
fever
tender
lymphaden
tonsillar
coat
well
potenti
confound
smoke
habit
recent
antibiot
treatment
histori
sore
throat
durat
symptom
prior
consult
sinc
studi
interfer
clinic
manag
risk
bia
minim
control
patient
year
old
visit
phcc
medic
reason
infect
recruit
control
group
time
period
inform
consent
obtain
sampl
perform
questionnair
includ
question
potenti
confound
recurr
sore
throat
smoke
habit
antibiot
treatment
last
month
complet
sampl
perform
staff
phcc
swab
cultur
streptococci
f
necrophorum
obtain
roll
swab
tonsil
side
place
ami
medium
charcoal
copan
brescia
itali
two
sampl
analys
respiratori
virus
mycoplasma
pneumonia
chlamydophila
pneumonia
obtain
use
flock
swab
transport
ml
univers
transport
medium
utm
copan
one
pharynx
one
nasopharynx
patient
group
capillari
blood
sampl
obtain
analysi
epsteinbarr
viru
ebv
specif
antibodi
accord
procedur
use
counti
time
studi
result
cultur
streptococci
report
physician
sampl
store
refriger
transport
depart
clinic
microbiolog
central
hospit
throat
swab
cultur
recoveri
streptococci
lancefield
group
c
g
use
doublelay
agar
columbia
agar
oxoid
basingstok
uk
cover
sheep
blood
agar
blood
agar
base
merck
darmstadt
germani
sheep
blood
sva
uppsala
sweden
mgml
methyl
violet
merck
darmstadt
germani
bacitracin
disc
iu
f
necrophorum
select
anaerob
plate
fastidi
anaerob
agar
lab
hors
blood
sva
supplement
vancomycin
mgl
icn
biomed
irvin
ca
usa
nalidix
acid
mgl
mp
biomed
santa
ana
ca
usa
kanamycin
tablet
rosco
taastrup
denmark
use
agar
plate
incub
anaerob
condit
day
respect
speci
identif
streptex
remel
europ
ltd
dartford
england
malditof
microflex
massspectromet
biotyp
softwar
bruker
dalton
bremen
germani
use
sampl
transport
utm
store
ship
dri
ice
depart
clinic
microbiolog
sahlgrenska
univers
hospit
gothenburg
sweden
analys
sampl
analys
use
multiplex
pcr
respiratori
virus
two
intracellular
bacteria
pneumonia
c
pneumonia
previous
describ
detect
dna
rna
consid
posit
result
blood
sampl
centrifug
rpm
minut
sera
store
analys
perform
sampl
screen
presenc
epsteinbarr
viru
nucleic
antigenantibodi
ebna
novagnost
ebvebna
igg
siemen
tarrytown
ny
usa
siemen
sampl
neg
ebna
analys
ebv
igm
enzygnost
antiebvigm
ii
siemen
ebvvir
capsid
antigen
igg
vca
igg
enzygnost
antiebv
igg
siemen
patient
posit
ebv
igm
without
vca
igg
consid
primari
ebv
infect
sampl
strategi
detect
techniqu
routin
diagnost
streptococci
cultur
influenza
b
pcr
pneumonia
pcr
chang
studi
period
sampl
analys
pathogen
retriev
li
system
adbakt
autonik
ab
sweden
depart
clinic
microbiolog
august
juli
proport
posit
sampl
analys
monthli
basi
compar
studi
data
abl
detect
differ
presenc
f
necrophorum
patient
control
patient
includ
given
power
valu
statist
analys
perform
use
spss
softwar
ibm
armonk
ny
usa
descript
statist
median
valu
proport
use
comparison
proport
categor
variabl
two
independ
group
perform
use
test
fisher
exact
test
expect
frequenc
small
multipl
logist
regress
use
model
relationship
outcom
variabl
sever
independ
variabl
kruskalw
test
use
compar
median
two
group
miss
data
variabl
among
patient
except
tonsillar
coat
miss
among
control
background
data
miss
individu
studi
approv
region
ethic
board
sweden
drn
patient
control
receiv
written
inform
studi
see
physician
patient
opportun
ask
question
studi
inform
consent
obtain
sampl
method
use
studi
well
establish
familiar
personnel
perform
sampl
thu
regard
safe
includ
patient
control
total
patient
control
recruit
median
age
year
rang
year
patient
group
year
rang
year
control
group
characterist
studi
popul
present
tabl
patient
evalu
accord
symptom
sign
build
centor
score
median
centor
score
present
centor
score
score
score
score
score
detect
bacteria
virus
patient
control
patient
compar
control
p
least
one
bacterium
viru
found
correspond
figur
virus
independ
presenc
bacteria
p
respect
least
one
bacterium
without
presenc
virus
found
patient
control
p
patient
one
microorgan
found
two
bacteria
virus
found
three
four
patient
common
combin
ga
f
necrophorum
n
six
control
posit
one
microorgan
distribut
bacteria
virus
found
present
see
result
section
ga
p
f
necrophorum
p
influenza
b
p
significantli
commonli
found
among
patient
among
control
repres
three
common
find
patient
group
bacteria
virus
found
patient
suspicion
pharyngotonsil
except
c
pneumonia
test
bacteria
virus
found
least
one
patient
patient
posit
bacteria
infect
one
bacteri
speci
concomit
find
least
one
viru
ga
common
find
n
follow
f
necrophorum
n
influenza
b
viru
n
rhinovirus
n
import
sampl
site
detect
virus
virus
found
either
throat
sampl
nasopharyng
sampl
supplementari
tabl
signific
differ
cycl
threshold
valu
cycl
threshold
differ
sampl
site
patient
viru
found
combin
bacteria
thu
indic
similar
amount
virus
sampl
sever
pathogen
detect
rate
patient
group
unevenli
distribut
studi
adenovirus
first
inclus
period
rhinovirus
second
period
influenza
b
first
period
found
separ
time
frame
studi
ga
f
necrophorum
isol
throughout
inclus
period
influenza
b
ga
rel
preval
studi
popul
given
time
relat
detect
rate
clinic
sampl
data
shown
associ
bacteria
virus
significantli
associ
diseas
ie
bacteria
virus
ga
f
necrophorum
influenza
b
viru
background
characterist
specif
symptom
sign
centor
score
present
tabl
patient
one
sever
bacteria
found
higher
median
centor
score
centor
score
median
patient
virus
centor
score
median
mannwhitney
u
test
p
patient
bacteria
virus
detect
centor
score
median
score
valu
patient
f
necrophorum
n
display
lower
centor
score
ga
n
higher
patient
influenza
b
virus
potenti
pathogen
found
kruskalw
p
multipl
regress
analysi
reveal
smoker
presenc
tonsillar
coat
import
likelihood
find
f
necrophorum
tabl
prospect
case
control
studi
analys
potenti
caus
agent
sore
throat
bacteria
virus
could
detect
least
one
patient
year
age
attend
phc
suspicion
pharyngotonsil
compar
asymptomat
control
age
ga
f
necrophorum
influenza
b
significantli
common
patient
highest
level
centor
score
found
patient
ga
sever
virus
influenza
b
adenoand
rhinoviru
ga
show
mark
season
variat
thu
contribut
differ
aetiolog
pharyngotonsil
given
time
point
far
know
first
prospect
studi
broad
diagnost
approach
includ
bacteria
virus
relat
report
sign
symptom
patient
age
year
suspicion
pharyngotonsil
high
qualiti
clinic
data
allow
us
perform
analys
relationship
specif
pathogen
patient
histori
symptom
sign
summer
consid
low
season
pharyngotonsil
therefor
includ
overal
centor
score
rel
low
clinic
assess
patient
guid
consid
limit
studi
howev
reflect
patient
group
practic
swedish
phc
therefor
consid
relev
studi
power
abl
detect
signific
differ
presenc
f
necrophorum
pharyngotonsil
patient
compar
control
group
sinc
power
calcul
associ
bacteria
virus
sign
symptom
may
miss
associ
encourag
studi
could
identifi
potenti
pathogen
patient
could
due
sampl
detect
method
use
howev
method
sampl
analys
sampl
use
may
use
clinic
set
thu
relev
noninfecti
caus
sore
throat
also
report
author
includ
studi
interestingli
median
centor
score
group
patient
bacterium
viru
found
centor
score
similar
group
virus
found
indic
may
infect
due
virus
rather
bacteria
undetect
group
expect
ga
common
pathogen
centor
score
patient
higher
patient
nonga
infect
support
continu
use
score
predict
presenc
ga
larg
divers
virus
contribut
aetiolog
tempor
variat
result
influenza
b
period
common
viral
caus
pharyngotonsil
age
group
respiratori
virus
also
detect
control
group
might
seen
overreport
presenc
virus
due
high
sensit
pcr
howev
would
argu
rather
reflect
asymptomat
infect
prolong
shed
virus
despit
unbias
inclus
mani
patient
cultureposit
f
necrophorum
healthi
control
posit
bacterium
previous
aliyu
et
al
describ
patient
age
month
year
sore
throat
routin
cultur
obtain
found
f
necrophorum
sampl
use
pcr
find
f
necrophorum
among
healthi
control
amess
report
routin
throat
cultur
age
group
year
posit
f
necrophorum
highest
preval
patient
age
year
patient
year
age
nonstreptococc
tonsil
jensen
et
al
identifi
f
necrophorum
pcr
almost
half
sampl
lower
amount
among
control
use
sampl
routin
microbiolog
nonstreptococc
sampl
tend
contrari
prospect
open
inclus
use
present
studi
overreport
pathogen
studi
fusobacterium
necrophorum
microorgan
found
patient
patient
necessarili
less
ill
patient
ga
receiv
lower
centor
score
due
higher
presenc
cough
although
power
studi
calcul
rule
associ
sign
symptom
studi
could
find
associ
age
recent
primari
ebv
infect
recurr
sore
throat
detect
f
necrophorum
suggest
other
howev
smoke
coat
tonsil
increas
likelihood
detect
f
necrophorum
importantli
control
posit
f
necrophorum
presenc
bacterium
thu
strictli
associ
symptom
among
nearli
twothird
patient
presenc
f
necrophorum
anoth
microorgan
found
ga
virus
growth
possibl
also
pathogen
potenti
f
necrophorum
may
thu
facilit
underli
inflamm
conclus
studi
show
ga
sever
respiratori
virus
togeth
f
necrophorum
import
aetiolog
pharyngotonsil
exact
distribut
specif
pathogen
given
time
subject
local
tempor
variat
centor
bank
et
al
suggest
broad
antibiot
treatment
tonsil
could
prevent
case
sever
infect
ie
syndrom
consid
suggest
prematur
find
f
necrophorum
predispos
tonsil
shown
import
develop
syndrom
best
treatment
option
f
necrophorum
yet
establish
studi
warrant
defin
import
f
necrophorum
tonsil
establish
standard
handl
find
f
necrophorum
pharyngotonsil
determin
whether
antibiot
treatment
need
urg
diagnost
laboratori
consid
method
need
find
bacterium
throat
swab
ie
pcrbase
methodolog
anaerob
cultur
day
studi
fund
unrestrict
grant
kronoberg
counti
council
nordic
societi
clinic
microbiolog
infecti
diseas
nscmid
south
swedish
region
council
swedish
societi
physician
sl
author
declar
conflict
interest
